Michael Richman

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

NXTC

Current role

CEO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	NextCure, Inc. (NXTC)	President and Chief Executive Officer	$609,258	—	—	$189,170	$122,000	$21,264	$941,692
2024	NextCure, Inc. (NXTC)	President and Chief Executive Officer	$591,483	—	—	$658,240	$240,500	$20,716	$1,510,939
2023	NextCure, Inc. (NXTC)	President and Chief Executive Officer	$571,875	—	—	$346,238	$106,400	$20,114	$1,044,627
2022	NextCure, Inc. (NXTC)	President and Chief Executive Officer	$549,375	—	—	$1,010,240	$151,300	$13,271	$1,724,186
2021	NextCure, Inc. (NXTC)	President and Chief Executive Officer	$529,167	—	—	$2,595,000	$194,300	$2,958	$3,321,425
2020	NextCure, Inc. (NXTC)	President and Chief Executive Officer	$490,969	—	—	$5,844,457	$150,000	$2,970	$6,488,396
2019	NextCure, Inc. (NXTC)	President and Chief Executive Officer	$418,534	—	—	—	$204,000	$3,145	$625,679
2018	NextCure, Inc. (NXTC)	President and Chief Executive Officer	$383,400	—	—	$1,963,224	$154,480	$493	$2,501,597

No earnings-call appearances or filed executive changes recorded yet.